Sandbox/table: Difference between revisions

Jump to navigation Jump to search
Guillermo Rodriguez Nava (talk | contribs)
No edit summary
Guillermo Rodriguez Nava (talk | contribs)
Line 14: Line 14:
==table==
==table==


{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 50%;"
{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 40%;"
|+ '''Laboratory findings'''
|+ '''Laboratory findings'''
|-
|-
Line 21: Line 21:
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[White blood cells]] count'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[White blood cells]] count'''
| style="background: #DCDCDC; padding: 5px;"| Leucopenia (1000 cells/μL), with lymphopenia and neutrophilia
| style="background: #DCDCDC; padding: 5px;"| Leucopenia (1000 cells/μL)<br>Lymphopenia<br>Neutrophilia
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Blood smear]]'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Blood smear]]'''
| style="background: #DCDCDC; padding: 5px;"| Left shift with atypical lymphocytes
| style="background: #DCDCDC; padding: 5px;"| [[Left shift]]<br>Atypical [[lymphocytes]]
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Liver function tests]]'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Liver function tests]]'''
| style="background: #DCDCDC; padding: 5px;"| Raised [[aspartate aminotransferase]] and [[alanine aminotransferase]], extended [[prothrombin time]] and [[partial thromboplastin time]].
| style="background: #DCDCDC; padding: 5px;"| Raised [[aspartate aminotransferase]]<br>Raised[[alanine aminotransferase]]<br>Extended [[prothrombin time]]<br>Extended[[partial thromboplastin time]].
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Proteins]]'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Proteins]]'''
Line 35: Line 35:
| style="background: #DCDCDC; padding: 5px;"| [[Proteinuria]].  
| style="background: #DCDCDC; padding: 5px;"| [[Proteinuria]].  
|}
|}


==table==
==table==

Revision as of 19:03, 20 June 2014

The following table contains the main risk factors for CDI:[1][2][3][2][2]

Alterations in the coagulation system
Consumption of clotting factors
Increased concentrations of fibrin degradation products
Disseminated intravascular coagulation

table

Laboratory findings
Test Findings
White blood cells count Leucopenia (1000 cells/μL)
Lymphopenia
Neutrophilia
Blood smear Left shift
Atypical lymphocytes
Liver function tests Raised aspartate aminotransferase
Raisedalanine aminotransferase
Extended prothrombin time
Extendedpartial thromboplastin time.
Proteins Hyperproteinemia.
Urinalysis Proteinuria.

table

Countries with a reported prevalence <15% of H. pylori resistance to clarithromycin
Diagnostic test North America South America Middle East Far East
ELISA (serology) detects:
  • Viral Antigen
  • IgM and IgG antibody | hol

There is a reported prevalence of 15% in the Northeast of the US.

  1. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
  2. 2.0 2.1 2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
  3. Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.